RxDoctor Payments Data

Tonya Howell

Family · Salisbury, MDNPI 1952689192

Payments from drug & device makers

$2,860in general payments, 2019–2025

Across 138 payments — averaging $20.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$432
  • Scpharmaceuticals Inc.$320
  • Boehringer Ingelheim$305
  • Boston Scientific$293
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$236
  • E.r. Squibb & Sons, L.L.C.$209
  • plus $1K from 17 others

What the payments were for

  • Food & beverage$2,846100%
  • Education$140%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,860 in reported general payments places this provider in the 85th percentile of 2,843 family providers in Maryland.

See all family providers in Maryland

Most prescribed under Part D

DrugClaimsCost to plans & patients
EntrestoSacubitril/Valsartan69$71,149
EliquisApixaban50$55,511
XareltoRivaroxaban43$35,105
BrilintaTicagrelor27$21,769
Repatha SureclickEvolocumab15$21,129
JardianceEmpagliflozin11$14,334
Metoprolol Succinate191$3,201
Hydralazine Hcl91$1,721
Olmesartan Medoxomil12$1,654
Furosemide161$1,270
Carvedilol115$1,082
Atorvastatin Calcium80$1,046
Ranolazine ErRanolazine17$938
Rosuvastatin Calcium34$819
Losartan Potassium98$798

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
NovartisEntresto$432$71,14969 claims
PfizerEliquis$157$55,51150 claims
Johnson & JohnsonXarelto$126$35,10543 claims
AstraZenecaBrilinta$84$21,76927 claims
Boehringer IngelheimJardiance$305$14,33411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,843 family providers in Maryland.

Other family in Salisbury

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →